Abeona Therapeutics Inc

Healthcare · Biotechnology

5.10$ +1.4% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Abeona Therapeutics Inc (ABEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 180 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABEO
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	74	111	105	97	96	179	176	167	161	174	166	159	143	223	175	164	159	151	141	131	119	80	55	45	39	64	53	54	66	64	75	134	121	109	99	246	231	220	198	180
Current Assets	32	69	64	59	58	141	134	122	115	89	72	65	50	132	119	109	105	98	89	79	68	56	39	30	25	53	43	44	57	56	67	126	113	101	88	232	216	205	183	165
Cash	31	69	63	58	57	138	132	50	34	19	26	43	48	129	40	15	8.4	13	14	27	44	33	20	6.1	5.7	14	4.7	6.2	4.7	14	18	34	16	23	16	164	83	78	61	56
Cash & Short-Term Investments	31	69	63	58	57	138	132	120	112	85	68	63	48	129	116	108	97	95	87	78	67	45	31	20	18	52	40	37	54	52	62	123	110	98	84	226	207	191	168	147
Receivables	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.0	0.0	–	–	7.0	–	–	–	–	3.0	0.0	2.9	1.0	0.2	0.5	5.7	2.2	2.4	2.2	1.6	1.6	1.7	1.6	1.6	1.6	6.7	6.7	9.9
Inventory	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	0.0	–	–	–	–	0.0	–	5.9	5.3	0.3	0.3	0.3	0.3	–	–	–	–	0.0	–	2.7	4.9	5.5	6.1	5.9
Property, Plant & Equipment	0.7	0.7	0.7	0.7	0.7	1.4	4.8	8.0	9.2	9.4	10	14	14	13	13	13	12	18	11	17	16	22	16	14	13	–	5.3	4.5	8.7	–	–	–	–	–	–	–	–	–	–	–
Goodwill	32	32	32	32	32	32	32	32	32	32	32	32	32	32	32	32	32	32	32	32	32	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	8.6	8.4	8.2	4.2	4.1	4.0	3.9	3.8	3.7	43	42	39	37	36	2.0	1.9	1.9	1.5	1.5	1.4	1.4	1.4	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	10	12	9.6	7.6	5.9	8.7	6.5	5.8	10	40	48	52	47	45	43	43	44	49	47	47	39	37	24	25	23	37	35	44	44	49	84	61	75	65	58	83	60	60	54	51
Current Liabilities	6.5	8.3	6.1	4.2	2.6	5.6	6.5	5.8	10	20	21	26	20	39	37	38	39	42	41	42	26	17	12	14	13	7.8	7.4	9.4	8.4	13	12	17	18	17	18	35	22	30	31	25
Short-Term Debt	–	–	–	-0.6	-0.6	-3.7	-0.5	–	–	10	12	12	12	1.7	1.7	3.5	3.5	2.0	2.3	3.5	1.7	1.8	1.8	1.8	1.8	1.8	1.8	1.6	1.6	1.0	1.0	4.0	5.5	6.7	8.8	6.1	9.0	13	15	15
Accounts Payable	1.9	3.7	1.5	3.6	2.0	1.9	5.9	5.8	10	6.1	4.2	7.2	2.7	3.8	1.8	2.0	1.3	4.7	2.5	1.5	1.9	4.3	1.6	1.7	1.7	1.8	2.9	3.5	2.6	1.9	3.4	3.1	2.8	3.4	5.0	7.3	5.9	7.9	4.1	3.0
Long-Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	20	20	20	–	–	–	–	1.4	1.2	–	–	–	–	–	–	–	–	–	–	–	18	16	14	13	11	14	11	7.8	4.8	1.7
Shareholders' Equity	63	99	96	89	90	170	169	161	150	134	118	107	96	178	132	121	115	103	94	84	80	42	31	20	15	27	19	9.3	22	15	-8.9	73	46	44	41	164	171	159	145	128
Retained Earnings	-325	-332	-338	-346	-351	-360	-365	-376	-393	-410	-429	-453	-470	-486	-535	-548	-555	-571	-587	-602	-609	-656	-676	-685	-694	-695	-704	-721	-733	-750	-781	-774	-804	-813	-825	-716	-722	-742	-759	-779
Shares Outstanding	1.3	1.6	1.6	1.6	1.6	1.9	1.9	1.9	1.9	1.9	1.9	2.0	2.0	3.7	3.7	3.7	3.7	3.7	3.8	3.9	3.9	4.2	5.8	5.8	6.4	7.1	17	18	25	26	27	51	48	41	50	67	54	66	57	57

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings